Schedule 13G ownership disclosure
Madrigal Pharmaceuticals Inc
Security class unavailable · CUSIP: 558868105
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,266,375
- Percent of class
- 7.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-016407
- Form type
- SC 13G
- Filer
- MADRIGAL PHARMACEUTICALS, INC.
- CIK
- CIK 1157601
- Filed
- Feb 09, 2023
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership